In double-label immunocytochemical experiments with podoplanin (D2–40) which distinguished lymphatics from blood vessels (CD31), the vast majority (>90%) of vascular structures containing tumor emboli were lymphatics (Figure 1E). The gene discussed is PDPN; the disease is neoplasm.